← Back to headlines
Eloxx Pharmaceuticals Reports GAAP EPS of -$0.66
Eloxx Pharmaceuticals has announced its GAAP Earnings Per Share (EPS) at -$0.66, reflecting its financial performance for the recent period.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
